drugset / Trial / NCT02416258

A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)

NCT02416258

Phase 2 Completed 50 enrolled LEO Pharma
RandomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the anti-psoriatic effect of LP0113 aerosol spray compared to Daivobet® gel, LEO 90100 aerosol foam, betamethasone dipropionate in the aerosol spray vehicle, calcipotriol in the aerosol spray vehicle and aerosol spray vehicle.

Timeline

Start
2015-04
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcipotriol Small molecule 50 unknown Topical
Comparator Daivobet Unknown 0.5 unknown Topical
Comparator Daivobet Unknown 50 unknown Topical
Comparator LEO 90100 Unknown 0.5 unknown Topical
Comparator LEO 90100 Unknown 50 unknown Topical
Comparator LP0113 Unknown
Comparator betamethasone dipropionate Small molecule 0.5 unknown Topical